Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Finished Goods (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Finished Goods for 15 consecutive years, with $5.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Finished Goods rose 23.38% to $5.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 23.38% increase, with the full-year FY2024 number at $5.2 million, up 1.99% from a year prior.
  • Finished Goods was $5.9 million for Q3 2025 at Harvard Bioscience, down from $5.9 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $6.8 million in Q1 2022 to a low of $4.8 million in Q3 2024.
  • A 5-year average of $5.6 million and a median of $5.5 million in 2024 define the central range for Finished Goods.
  • Peak YoY movement for Finished Goods: surged 32.93% in 2022, then fell 24.33% in 2023.
  • Harvard Bioscience's Finished Goods stood at $5.6 million in 2021, then dropped by 7.49% to $5.2 million in 2022, then fell by 1.97% to $5.1 million in 2023, then rose by 1.99% to $5.2 million in 2024, then grew by 12.27% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Finished Goods are $5.9 million (Q3 2025), $5.9 million (Q2 2025), and $5.1 million (Q1 2025).